Huwel Lifesciences and ASMS Partner to Accelerate Southeast Asia Healthcare Expansion

Huwel Lifesciences and ASMS Partner to Accelerate Southeast Asia Healthcare Expansion​

National, April 27, 2026: Huwel Lifesciences and Avio Smart Market Stack Limited (ASMS) have announced a strategic international expansion through the onboarding of a Singapore-based regional commercialization partner. This collaboration is aimed at driving market access and robust business growth across the Southeast Asia region.

The partnership is designed to build a scalable export platform across key markets. These regions include Singapore, Indonesia, Malaysia, Thailand, Vietnam, and the Philippines. This market selection is driven by the rising healthcare investments, growing diagnostic awareness, and rapid expansion of laboratory infrastructure witnessed in Southeast Asia.

The region is highlighted as one of the fastest-growing healthcare opportunity zones globally, fueled by large populations, increasing urbanization, expanding medical tourism, and a heightened focus on public health preparedness and infectious disease management. Government bodies across Southeast Asia are actively investing in screening infrastructure, laboratory modernization, women's health diagnostics, and decentralized testing systems.

Under the terms of the partnership, ASMS will take the lead in commercial execution. Its responsibilities include strategic sales development, establishing channel partnerships, and planning the regional rollout. Meanwhile, Huwel Lifesciences will concentrate on technology development, manufacturing, regulatory support, and product innovation.

The market entry will be anchored by Quantiplus, Huwel's flagship molecular diagnostics platform. This product was chosen as the lead offering due to its affordability, scalability, and clinical reliability, making it highly suitable for institutional, laboratory, and public health applications across high-volume and cost-sensitive healthcare systems.

Mr. N. Vidhya Sagar Reddy, Managing Director of ASMS, commented on the development, stating, "This collaboration marks an important step in building our healthtech vertical as a long-term growth driver. By leveraging our strengths in market development and execution, we aim to create a strong commercialization ecosystem for Huwel's innovations across Southeast Asia. It also aligns with our broader vision of building diversified, future-ready businesses across healthcare, agriculture, and digital commerce."

Following the initial rollout, the partnership plans to introduce additional solutions from Huwel's diagnostics portfolio. These include portable testing platforms, decentralized molecular systems, rapid screening solutions, and specialized diagnostic applications tailored to regional healthcare requirements.

For ASMS, this development significantly strengthens its emerging healthtech vertical, complementing its established focus on financial inclusion and agritech initiatives. The company views healthcare technology as a key long-term growth driver with both domestic and international potential.

The collaboration is set to establish a strong export engine for next-generation healthcare solutions by integrating Huwel's scientific capabilities with ASMS's market execution expertise. This move reinforces India's growing stature as a global hub for advanced, cost-efficient diagnostics, positioning Southeast Asia as a major milestone in the companies' international expansion journey.

ASMS Stock Price Movement​

Shares of Bartronics India Limited are edging higher to ₹8.14 as of 12:00 PM today, rallying 1.75% in live trading. Trading activity remains strong, with the stock currently recording a volume of 711,788 shares.